Fuelled by high oil prices, Russia’s economy has surged at a hefty 6 percent-plus rate since 1998, producing big income gains for some groups of workers. A key question, however, is whether the boom is substantially improving the lives of the general population, says BusinessWeek’s Gene Koretz.
The answer suggested
It’s been over 20 years since American women reached near parity in university architecture programmes. But only now are female architects populating the professional ranks in greater numbers and taking on leadership roles at firms, according to new statistics.
The percentage of licensed architects who are women grew to
The Policy Analysis Market (PAM) was to have been a market in which participants could wager on Middle East events say, the gross domestic product of Syria in coming years or the political stability of Iran.
Critics labelled the project a “terrorism futures market” and denounced it as
In New York City, some 1,800 children are being schooled at home. At least 850,000 children in the U.S. are schooled at home, up from 360,000 a decade ago, according to the Education Department.
Many come to home schooling because of frustration with the shortcomings of public education and
There is an important debate now taking place among monetary policy analysts over the question of “capacity utilisation.” Its resolution will tell us much about the future course of the U.S. economy, says Bruce Bartlett.
The theory is that if the economy has substantial unused capacity for production, then monetary
Some trade protectionists disguise their support for high tariffs and quotas on imports by claiming that “free trade and open markets only work if both economies operate under the same rules,” as U.S. Commerce Secretary Don Evans wrote recently in the Wall Street Journal.
That is false, points out economist Alan
Most price comparisons that find drug prices much higher in the United States than other parts of the world are flawed, say researchers Patricia Danzon and Michael Furukawa. Their research found that U.S.-foreign price differentials are roughly in line with income and are smaller for drugs than for other
